# Evaluating the risk of metabolic syndrome after psychotropic medication in autism spectrum disorder: A survival analysis
R scripts to identify the ASD patients with at least one new metabolic syndrome-related condition and exposed to psychotropic medications, definition of psychotropic polypharmacy, and survival analysis (cox proportional hazard model) for the metabolic-syndrome related conditions.  

